TY - JOUR
T1 - Cellular localization of the endothelin receptor subtypes ETA and ETB in the rat heart and their differential expression in coronary arteries, veins, and capillaries
AU - Wendel-Wellner, Martina
AU - Noll, Thomas
AU - König, Peter
AU - Schmeck, Joachim
AU - Koch, Thea
AU - Kummer, Wolfgang
N1 - Funding Information:
Acknowledgements The authors wish to thank Mrs. K. Michael and Mrs. P. Hartmann for their excellent technical assistance, and Mr. M. Bodenbenner for the care and handling of the animals. This work was supported by a grant from the Deutsche For-schungsgemeinschaft (DFG KO 1814/2-1).
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2002
Y1 - 2002
N2 - In the heart, the endothelin (ET)/endothelin-receptor system is markedly involved in pathophysiological mechanisms underlying various cardiac diseases. Based upon pharmacological studies both ET-receptor subtypes take part in the regulation of coronary vascular tone, however, their detailed cellular distribution in the coronary vascular bed based upon direct mRNA and protein detection is unknown. This issue was addressed in the rat heart by means of non-radioactive in situ hybridization, RT-PCR, and immunohistochemistry. Expression of vascular ETA-receptors was detected in arterial smooth muscle and capillary endothelium while ETB-receptors were present in arterial, venous, and capillary endothelium, and in arterial and venous smooth muscle cells. This differential distribution of the ET-receptor subtypes supports the concept that ETA- as well as ETB-receptors mediate arterial vasoconstriction, while postcapillary vascular resistance is exclusively regulated by ETB-receptors. The observed capillary endothelial expression of the ETA-receptor correlates with the known ability of ETA-receptor antagonists to attenuate increases in cardiac microvascular permeability during endotoxin shock and ischemia/reperfusion injury.
AB - In the heart, the endothelin (ET)/endothelin-receptor system is markedly involved in pathophysiological mechanisms underlying various cardiac diseases. Based upon pharmacological studies both ET-receptor subtypes take part in the regulation of coronary vascular tone, however, their detailed cellular distribution in the coronary vascular bed based upon direct mRNA and protein detection is unknown. This issue was addressed in the rat heart by means of non-radioactive in situ hybridization, RT-PCR, and immunohistochemistry. Expression of vascular ETA-receptors was detected in arterial smooth muscle and capillary endothelium while ETB-receptors were present in arterial, venous, and capillary endothelium, and in arterial and venous smooth muscle cells. This differential distribution of the ET-receptor subtypes supports the concept that ETA- as well as ETB-receptors mediate arterial vasoconstriction, while postcapillary vascular resistance is exclusively regulated by ETB-receptors. The observed capillary endothelial expression of the ETA-receptor correlates with the known ability of ETA-receptor antagonists to attenuate increases in cardiac microvascular permeability during endotoxin shock and ischemia/reperfusion injury.
UR - http://www.scopus.com/inward/record.url?scp=0036434389&partnerID=8YFLogxK
U2 - 10.1007/s00418-002-0457-4
DO - 10.1007/s00418-002-0457-4
M3 - Journal articles
C2 - 12432447
AN - SCOPUS:0036434389
SN - 0948-6143
VL - 118
SP - 361
EP - 369
JO - Histochemistry and Cell Biology
JF - Histochemistry and Cell Biology
IS - 5
ER -